4D Molecular Therapeutics, Inc. FDMT
FDMT
4D Molecular Therapeutics, Inc. KALV
KalVista Pharmaceuticals, Inc. OMER
Omeros Corporation BCYC
Bicycle Therapeutics plc GOSS
Gossamer Bio, Inc. LXRX
Lexicon Pharmaceuticals, Inc. ADCT
ADC Therapeutics S.A. NMRA
Neumora Therapeutics, Inc. Common Stock RGNX
REGENXBIO Inc. PRTA
Prothena Corporation plc
4D Molecular Therapeutics, Inc. KALV
KalVista Pharmaceuticals, Inc. OMER
Omeros Corporation BCYC
Bicycle Therapeutics plc GOSS
Gossamer Bio, Inc. LXRX
Lexicon Pharmaceuticals, Inc. ADCT
ADC Therapeutics S.A. NMRA
Neumora Therapeutics, Inc. Common Stock RGNX
REGENXBIO Inc. PRTA
Prothena Corporation plc
Performance
| Periode | FDMT | KALV | OMER | BCYC | GOSS | LXRX | ADCT | NMRA | RGNX | PRTA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 135.12 % | 13.72 % | 195.62 % | -17.71 % | 176.00 % | 87.56 % | -4.22 % | 103.43 % | 29.66 % | 96.20 % |
| YTD | 80.27 % | 82.39 % | 16.57 % | -50.49 % | 255.67 % | 69.22 % | 75.75 % | 5.33 % | 61.83 % | -24.51 % |
| 1Y | 45.17 % | 71.19 % | 8.82 % | -65.92 % | 366.91 % | 79.67 % | 1.01 % | -80.03 % | 30.33 % | -29.07 % |
| 3Y | -58.72 % | 173.43 % | 438.50 % | -76.67 % | 58.26 % | -37.97 % | 13.39 % | -87.23 % | -44.04 % | -83.23 % |
| 5Y | -74.05 % | -7.82 % | -19.11 % | -62.60 % | -64.29 % | -60.39 % | -89.62 % | -87.23 % | -67.26 % | -9.79 % |
| 10Y | -74.05 % | -65.34 % | -18.94 % | -40.75 % | -80.77 % | -89.63 % | -88.15 % | -87.23 % | -34.74 % | -84.93 % |
| Depuis le début | -74.05 % | -79.24 % | 31.39 % | -40.75 % | -80.77 % | -99.00 % | -88.15 % | -87.23 % | -58.23 % | 43.33 % |